Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernadette Porter

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
AACN Clinical Issues|May 16, 2002
The role of the advanced practice nurse in anticoagulationBernadette Porter
British Journal of Nursing (Mark Allen Publishing)|March 25, 2005
Supporting people with long-term conditionsBernadette Porter
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 29, 2017
Commentary on "Localized pigmentation disorder after subcutaneous pegylated interferon beta 1a injection" by Coghe et alBernadette Porter
British Journal of Nursing (Mark Allen Publishing)|June 28, 2003
Nursing at a specialist diagnostic clinic for multiple sclerosisBernadette Porter, Elizabeth Keenan
British Journal of Nursing (Mark Allen Publishing)|August 24, 2006
IV steroids for MS relapse: clinical governance implicationsEmily Harrison, Bernadette Porter
British Journal of Nursing (Mark Allen Publishing)|November 19, 2004
A nurse-led, patient-centred mitoxantrone service in neurologyEmily Harrison, Bernadette Porter
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|October 3, 2003
Disease-modifying drugs in multiple sclerosisElizabeth Keenan, Bernadette Porter
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 5, 2012
Connecting to the future--the promise of telecareBernadette Porter, Alan Thompson
Health and Quality of Life Outcomes|September 28, 2011
A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS)Afsane Riazi, Bernadette Porter, Jeremy Chataway, et al.
Pharmacotherapy|June 18, 2002
Point-of-care versus laboratory monitoring of patients receiving different anticoagulant therapiesRobert A Reiss, Curtis E Haas, Deborah L Griffis, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
AACN Clinical Issues|May 16, 2002
The role of the advanced practice nurse in anticoagulationBernadette Porter
British Journal of Nursing (Mark Allen Publishing)|March 25, 2005
Supporting people with long-term conditionsBernadette Porter
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 29, 2017
Commentary on "Localized pigmentation disorder after subcutaneous pegylated interferon beta 1a injection" by Coghe et alBernadette Porter
British Journal of Nursing (Mark Allen Publishing)|June 28, 2003
Nursing at a specialist diagnostic clinic for multiple sclerosisBernadette Porter, Elizabeth Keenan
British Journal of Nursing (Mark Allen Publishing)|August 24, 2006
IV steroids for MS relapse: clinical governance implicationsEmily Harrison, Bernadette Porter
British Journal of Nursing (Mark Allen Publishing)|November 19, 2004
A nurse-led, patient-centred mitoxantrone service in neurologyEmily Harrison, Bernadette Porter
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|October 3, 2003
Disease-modifying drugs in multiple sclerosisElizabeth Keenan, Bernadette Porter
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 5, 2012
Connecting to the future--the promise of telecareBernadette Porter, Alan Thompson
Health and Quality of Life Outcomes|September 28, 2011
A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS)Afsane Riazi, Bernadette Porter, Jeremy Chataway, et al.
Pharmacotherapy|June 18, 2002
Point-of-care versus laboratory monitoring of patients receiving different anticoagulant therapiesRobert A Reiss, Curtis E Haas, Deborah L Griffis, et al.
Pageof 2